The question of whether gender-affirming care lowers suicide risk for youth is a subject of significant scientific and public debate. While some observational studies report an association between medical interventions and reduced suicidal ideation, major systematic reviews and other analyses have concluded that the evidence base is weak and does not establish a clear causal link.

### Evidence Suggesting a Reduced Risk

Several studies suggest a positive correlation between gender-affirming care and mental health outcomes, including a reduction in suicidality.

*   A 2020 study in *Pediatrics* analyzed data from a large survey of transgender adults. It found that those who had access to puberty blockers during adolescence had lower odds of lifetime suicidal ideation compared to those who desired but did not receive them [1].
*   A 2022 study in *JAMA Network Open* followed a cohort of transgender and nonbinary youth aged 13-20 for one year. The study reported that receiving gender-affirming medical interventions (puberty blockers or hormones) was associated with 60% lower odds of moderate to severe depression and 73% lower odds of suicidality over the 12-month period [6].
*   A 2023 study in the *New England Journal of Medicine* followed 315 transgender and nonbinary youth for two years after they began hormone treatment. The study found that appearance congruence, body satisfaction, and overall quality of life improved, while depression and anxiety scores decreased. While not a direct measure of suicide attempts, these improvements in psychosocial functioning are considered relevant to suicide risk [7].

### Critiques and Findings of Weak Evidence

Despite these findings, several comprehensive reviews and critiques have raised serious concerns about the quality and certainty of the available evidence.

*   **The Cass Review:** An independent review commissioned by England's National Health Service (NHS), the Cass Review's interim report concluded that the evidence base for gender-affirming care in youth is "thin" and of "poor quality." The review noted a lack of long-term follow-up studies and the fact that existing studies are often small and observational, making it difficult to separate the effects of medical treatment from the effects of the supportive clinical care that accompanies it. The review described the evidence base as being built on "a house of cards" [3].
*   **Internal U.S. HHS Review:** An internal, non-publicized review of evidence conducted by the U.S. Department of Health and Human Services (HHS) in 2022 systematically analyzed existing studies. It concluded that the research did not provide reliable evidence of a causal link between gender-affirming treatment and improved mental health outcomes for adolescents [4]. The review found that studies suffered from major limitations, including a lack of control groups, small sample sizes, and a high risk of bias, making it impossible to draw firm conclusions about the benefits of hormonal interventions [4, 8]. The lead author of this review later stated that "the current evidence base does not support the claim that gender-affirming medical interventions reduce the risk of suicide" [8].
*   **Methodological Critiques:** Critics have highlighted significant flaws in some of the key studies suggesting a benefit. For instance, an analysis by journalist Jesse Singal pointed out that the 2022 *JAMA Network Open* study [6] reported statistically significant positive results, whereas the clinic's own internal report on the same data had previously stated that "changes in depression and anxiety scores were not statistically significant." This raises questions about how the data was analyzed and presented in the final publication [2, 9].

### Complex and Nuanced Findings

The relationship between gender-affirming care and mental health is further complicated by findings that show varied outcomes. A 2025 study in *The Journal of Sexual Medicine* analyzed a large national database to examine suicide attempts after gender-affirming surgery. It found differing outcomes based on birth-assigned sex:
*   Transmasculine individuals (assigned female at birth) had a **decreased** risk of suicide attempts after surgery.
*   Transfeminine individuals (assigned male at birth) had an **increased** risk of suicide attempts after surgery compared to a control group of cisgender individuals with a history of psychiatric diagnoses [5].

This highlights that the effects of gender-affirming interventions may not be uniform and can differ significantly between different populations within the transgender community.

In conclusion, while some observational studies associate gender-affirming care with a lower risk of suicidal ideation in youth, this link is contested. Major systematic reviews from health bodies like the NHS [3] and an internal HHS team [4, 8] have found the evidence to be of low quality and insufficient to establish a causal relationship. Critics also point to methodological flaws in key studies [2, 9]. The consensus is that transgender youth experience high rates of mental distress and require support; however, the specific impact of medical interventions on suicide risk remains an area of active debate and scientific uncertainty.

***

### Sources

1.  **[Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext)** - *Pediatrics*. This study surveyed transgender adults and found an association between having received puberty blockers in adolescence and lower odds of lifetime suicidal ideation.
2.  **[Researchers Found Puberty Blockers and Hormones Didn’t Improve Trans Kids’ Mental Health at Their Clinic — Then They Published a Study Claiming the Opposite](https://jessesingal.substack.com/p/researchers-found-puberty-blockers)** – *Singal-Minded (Jesse Singal)*. This article critiques a key study published in *JAMA Network Open*, alleging that the published findings contradict the clinic's earlier, non-significant findings on the same data, thereby questioning the paper's conclusion that care improved mental health.
3.  **[Independent Review of Gender Identity Services for Children and Young People: Interim Report](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf)** – *Cass Review (NHS England)*. This independent review for the NHS concludes that the evidence base for gender-affirming care for youth is of "poor quality," noting a lack of controlled trials and poor long-term outcome data. It expresses caution about the affirmative model and the certainty of benefits.
4.  **[Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf)** – *U.S. Department of Health and Human Services*. This internal HHS review, not publicly released by the agency, systematically analyzed the available evidence and concluded it was of "low-quality" and insufficient to support claims that medical interventions improve mental health outcomes for youth.
5.  **[Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063)** – *The Journal of Sexual Medicine*. This study found differing suicide attempt risks after gender-affirming surgery: a decreased risk for transmasculine individuals but an increased risk for transfeminine individuals, complicating a simple narrative of benefit.
6.  **[Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care](https://pubmed.ncbi.nlm.nih.gov/35212746/)** – *JAMA Network Open*. This observational study reports that receiving puberty blockers or hormones was associated with lower odds of depression and suicidality in transgender and nonbinary youth over a 12-month period.
7.  **[Psychosocial Functioning in Transgender Youth after 2 Years of Hormones](https://pubmed.ncbi.nlm.nih.gov/36652355/)** – *New England Journal of Medicine*. This study found that after two years of hormone treatment, transgender youth showed improved psychosocial functioning, including higher life satisfaction and lower depression and anxiety scores.
8.  **[I co-wrote the anonymous HHS report on pediatric gender medicine](https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/)** – *The Washington Post*. An op-ed by a lead author of the internal HHS review, explaining its conclusion that the evidence does not support claims that medical interventions for gender dysphoria reduce suicide risk in youth.
9.  **[The Liberal Misinformation Bubble About Youth Gender Medicine](https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/)** – *The Atlantic*. This article argues that the public and media narrative around gender-affirming care overstates the certainty of the scientific evidence, pointing to the conclusions of systematic reviews like the Cass Review and the internal HHS report.